Targeting of DDR1 with antibody-drug conjugates has antitumor effects in a mouse model of colon carcinoma.
Tao Y, Wang R, Lai Q, Wu M, Wang Y, Jiang X, Zeng L, Zhou S, Li Z, Yang T, Yao Y, Wu Y, Yu L, Fu Y, Lai W, Peng Y, Lu Y, Zhang Z, Guo C, Zhang G, Gou L, Yang J.
Tao Y, et al. Among authors: zhou s.
Mol Oncol. 2019 Sep;13(9):1855-1873. doi: 10.1002/1878-0261.12520. Epub 2019 Jul 22.
Mol Oncol. 2019.
PMID: 31116512
Free PMC article.